Protocol No
IIT-AKHTAR-CILTA-TALQ
Staff Member
Othman S Akhtar
Phase
I
Summary
This project is being done to look at the safety and feasibility of using talquetamab as a bridging therapy followed by cilta-cel infusion.
Objective
Study of talquetamab in patients with R/R multiple myeloma
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov